Noticias de ROIV_US

Mercado

Noticias del mercado

Últimas noticias sobre ROIV_US — 201 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.

Ticker: ROIV_US ✕ 201 resultados
08/09/2026 ROIV_US — Investing.com
Why is Roivant Sciences stock surging today? By Investing.com
08/09/2026 ROIV_US — Yahoo Finance
Roivant's experimental lung disease drug meets goals in mid-stage study
08/09/2026 ROIV_US — Benzinga
Roivant Sciences, Pharvaris, IonQ And Other Big Stocks Moving Higher On Tuesday
08/09/2026 ROIV_US — Yahoo Finance
Roivant’s Experimental Lung Disease Drug Hits Key Phase 2 Goal – ROIV Stock Tracks All-Time High
08/09/2026 ROIV_US — MarketScreener
Transcript : Roivant Sciences Ltd. Presents at Wells Fargo 21st Annual Healthcare Conference, Sep-08-2026 10
08/09/2026 ROIV_US — Yahoo Finance
Roivant surges on ‘exceptional’ results; Bristol Myers touts first-of-its-kind CAR-T therapy
08/09/2026 ROIV_US — Yahoo Finance
Roivant (ROIV) Soars to All-Time High; Q2 Hedge Fund Holdings Surge 41%
08/09/2026 ROIV_US — Yahoo Finance
Roivant Sciences Shares Rise After Phase 2 Mosliciguat Results
08/09/2026 ROIV_US — Seeking Alpha
Roivant Sciences soars 19% on positive mosliciguat trial results (ROIV:NASDAQ)
08/09/2026 ROIV_US — Barron's
S&P 500 Futures Decline in Premarket Trading; Roivant Sciences, Bloom Energy Lead
08/09/2026 ROIV_US — Yahoo Finance
These 2 Biotech Stocks Hit Record Highs Today – What’s Driving The Rallies?
08/09/2026 ROIV_US — Stock Titan
Roivant Sciences (NASDAQ: ROIV) director moves to sell shares after option exercise
08/09/2026 ROIV_US — StocksToTrade
ROIV Stock Jumps As FDA Clears LISRAYA And Analysts Hike Targets
08/09/2026 ROIV_US — Yahoo Finance
Roivant Stock Surges on 'Robust' Data from Rare Lung Disease Candidate
08/09/2026 ROIV_US — Stock Titan
Up to 200,000 PH-ILD patients lack options as Roivant (NASDAQ: ROIV) moves mosliciguat into a Phase 3 trial
08/09/2026 ROIV_US — Timothy Sykes
ROIV Stock Jumps As LISRAYA FDA Approval Ignites Momentum
08/09/2026 ROIV_US — Seeking Alpha
Roivant stock climbs on mid-stage trial win (ROIV:NASDAQ)
08/09/2026 ROIV_US — Investing.com
Roivant Sciences stock surges on positive PH-ILD trial data
08/09/2026 ROIV_US — Benzinga
Why Is Roivant Stock Trading Higher Today? - Roivant Sciences (NASDAQ:ROIV)
08/09/2026 ROIV_US — Yahoo Finance
Roivant Announces Positive Results from PHocus Study of Mosliciguat in Patients with Pulmonary Hypertension Associated with Interstitial Lung Disease (PH-ILD) and Unveils Ongoing Phase 3 PHrontier Study

Página 8 de 11